BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan Read more
FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma Read more
Boehringer and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance Read more
Deciphera and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China Read more
FDA Grants Genentech’s Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma Read more